Your browser doesn't support javascript.
loading
Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function.
Riopel, Matthew; Seo, Jong Bae; Bandyopadhyay, Gautam K; Li, Pingping; Wollam, Joshua; Chung, Heekyung; Jung, Seung-Ryoung; Murphy, Anne; Wilson, Maria; de Jong, Ron; Patel, Sanjay; Balakrishna, Deepika; Bilakovics, James; Fanjul, Andrea; Plonowski, Artur; Koh, Duk-Su; Larson, Christopher J; Olefsky, Jerrold M; Lee, Yun Sok.
Affiliation
  • Riopel M; Department of Medicine, Division of Endocrinology and Metabolism, UCSD, La Jolla, California, USA.
  • Seo JB; Department of Medicine, Division of Endocrinology and Metabolism, UCSD, La Jolla, California, USA.
  • Bandyopadhyay GK; Department of Physiology and Biophysics, University of Washington, Seattle, Washington, USA.
  • Li P; Department of Medicine, Division of Endocrinology and Metabolism, UCSD, La Jolla, California, USA.
  • Wollam J; Department of Medicine, Division of Endocrinology and Metabolism, UCSD, La Jolla, California, USA.
  • Chung H; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Jung SR; Department of Medicine, Division of Endocrinology and Metabolism, UCSD, La Jolla, California, USA.
  • Murphy A; Department of Medicine, Division of Endocrinology and Metabolism, UCSD, La Jolla, California, USA.
  • Wilson M; Department of Physiology and Biophysics, University of Washington, Seattle, Washington, USA.
  • de Jong R; Department of Pharmacology, UCSD, La Jolla, California, USA.
  • Patel S; Cardiovascular and Metabolic Diseases Drug Discovery Unit, Takeda Pharmaceuticals, San Diego, California, USA.
  • Balakrishna D; Cardiovascular and Metabolic Diseases Drug Discovery Unit, Takeda Pharmaceuticals, San Diego, California, USA.
  • Bilakovics J; Cardiovascular and Metabolic Diseases Drug Discovery Unit, Takeda Pharmaceuticals, San Diego, California, USA.
  • Fanjul A; Cardiovascular and Metabolic Diseases Drug Discovery Unit, Takeda Pharmaceuticals, San Diego, California, USA.
  • Plonowski A; Cardiovascular and Metabolic Diseases Drug Discovery Unit, Takeda Pharmaceuticals, San Diego, California, USA.
  • Koh DS; Cardiovascular and Metabolic Diseases Drug Discovery Unit, Takeda Pharmaceuticals, San Diego, California, USA.
  • Larson CJ; Cardiovascular and Metabolic Diseases Drug Discovery Unit, Takeda Pharmaceuticals, San Diego, California, USA.
  • Olefsky JM; Department of Physiology and Biophysics, University of Washington, Seattle, Washington, USA.
  • Lee YS; Cardiovascular and Metabolic Diseases Drug Discovery Unit, Takeda Pharmaceuticals, San Diego, California, USA.
J Clin Invest ; 128(4): 1458-1470, 2018 04 02.
Article in En | MEDLINE | ID: mdl-29504946
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Recombinant Fusion Proteins / Immunoglobulin Fc Fragments / Insulin-Secreting Cells / Chemokine CX3CL1 / Insulin Secretion Limits: Animals Language: En Journal: J Clin Invest Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Recombinant Fusion Proteins / Immunoglobulin Fc Fragments / Insulin-Secreting Cells / Chemokine CX3CL1 / Insulin Secretion Limits: Animals Language: En Journal: J Clin Invest Year: 2018 Document type: Article Affiliation country: Country of publication: